← Back
$ERNA All transactions

Ernexa Therapeutics Inc.

▲ BUY
5 / 10

Conviction

$ Value

Shares

4,000,000

Price

Filed

Feb 17

Why this score? (5/10)
  • Open market buy (+3)
  • 10%+ owner (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Cherington Charles

Title

CIK

0001448698

Roles

10% Owner

Transaction Details

Transaction Date

2026-02-10

Code

P

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

4,000,000

Footnotes

These shares and warrants were purchased by the reporting person in the Issuer's follow-on offering pursuant to a prospectus supplement dated February 6, 2026, which closed on February 10, 2026. | The combined purchase price in the Offering per share of Common Stock and accompanying warrant was $0.50. | The warrants will expire on the earlier of (i) February 10, 2031 or (ii) the 180th calendar day following the public release by the Company of clinical trial data from the first cohort of the Phase 1 study of ERNA-101.

Filing Info

Accession No.

0001104659-26-016680

Form Type

4

Issuer CIK

0000748592

Cherington Charles's History

Date Ticker Type Value
2026-02-10 ERNA $2.0M
2026-02-10 ERNA
2025-06-09 ERNA $2.2M
2024-09-24 ERNA
2024-09-24 ERNA
2024-09-24 ERNA
2024-09-24 ERNA
2024-09-24 ERNA
2024-09-24 ERNA
2024-09-24 ERNA

Other Insiders at ERNA (90d)

Insider Bought Sold Last
Cherington Charles $2.0M 2026-02-10